chr4-122612707-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_021803.4(IL21):c.*3A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00178 in 1,600,320 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0025 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 32 hom. )
Consequence
IL21
NM_021803.4 3_prime_UTR
NM_021803.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.381
Genes affected
IL21 (HGNC:6005): (interleukin 21) This gene encodes a member of the common-gamma chain family of cytokines with immunoregulatory activity. The encoded protein plays a role in both the innate and adaptive immune responses by inducing the differentiation, proliferation and activity of multiple target cells including macrophages, natural killer cells, B cells and cytotoxic T cells. Dysregulation of this gene plays a role in multiple immune-mediated diseases including lupus, psoriasis and chronic inflammatory diseases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 4-122612707-T-G is Benign according to our data. Variant chr4-122612707-T-G is described in ClinVar as [Benign]. Clinvar id is 3055532.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00253 (386/152294) while in subpopulation EAS AF= 0.0249 (129/5182). AF 95% confidence interval is 0.0214. There are 2 homozygotes in gnomad4. There are 235 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL21 | NM_021803.4 | c.*3A>C | 3_prime_UTR_variant | 5/5 | ENST00000648588.1 | NP_068575.1 | ||
IL21 | NM_001207006.3 | c.*120A>C | 3_prime_UTR_variant | 4/4 | NP_001193935.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL21 | ENST00000648588.1 | c.*3A>C | 3_prime_UTR_variant | 5/5 | NM_021803.4 | ENSP00000497915 | P1 | |||
IL21 | ENST00000647784.1 | n.344A>C | non_coding_transcript_exon_variant | 4/4 | ||||||
IL21 | ENST00000611104.2 | downstream_gene_variant | 1 | ENSP00000477555 |
Frequencies
GnomAD3 genomes AF: 0.00253 AC: 385AN: 152176Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
385
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00395 AC: 989AN: 250506Hom.: 14 AF XY: 0.00396 AC XY: 537AN XY: 135456
GnomAD3 exomes
AF:
AC:
989
AN:
250506
Hom.:
AF XY:
AC XY:
537
AN XY:
135456
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00170 AC: 2465AN: 1448026Hom.: 32 Cov.: 28 AF XY: 0.00186 AC XY: 1345AN XY: 721504
GnomAD4 exome
AF:
AC:
2465
AN:
1448026
Hom.:
Cov.:
28
AF XY:
AC XY:
1345
AN XY:
721504
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00253 AC: 386AN: 152294Hom.: 2 Cov.: 32 AF XY: 0.00316 AC XY: 235AN XY: 74470
GnomAD4 genome
AF:
AC:
386
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
235
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
49
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
IL21-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at